Compare PGEN & NHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PGEN | NHI |
|---|---|---|
| Founded | 1998 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 3.2B |
| IPO Year | 2013 | 1994 |
| Metric | PGEN | NHI |
|---|---|---|
| Price | $7.02 | $66.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 8 |
| Target Price | $13.65 | ★ $78.50 |
| AVG Volume (30 Days) | ★ 4.5M | 267.0K |
| Earning Date | 11-04-2026 | 11-09-2026 |
| Dividend Yield | N/A | ★ 5.62% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.03 | ★ 1.97 |
| Revenue | $230,981,000.00 | ★ $375,628,000.00 |
| Revenue This Year | $2,335.22 | $20.56 |
| Revenue Next Year | $85.34 | $6.66 |
| P/E Ratio | $223.17 | ★ $33.97 |
| Revenue Growth | N/A | ★ 12.07 |
| 52 Week Low | $3.04 | $63.51 |
| 52 Week High | $8.98 | $91.38 |
| Indicator | PGEN | NHI |
|---|---|---|
| Relative Strength Index (RSI) | 50.05 | 52.38 |
| Support Level | $6.57 | $63.51 |
| Resistance Level | $7.44 | $74.17 |
| Average True Range (ATR) | 0.42 | 1.37 |
| MACD | -0.03 | 0.35 |
| Stochastic Oscillator | 55.14 | 73.68 |
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
National Health Investors Inc is a self-managed REIT that owns, leases, operates, and finances the development of senior housing communities and medical facilities. It operates through two segments: Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates the majority of revenue, includes real estate leases, mortgages, and other notes receivable related to independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment consists of ventures that own and operate independent living facilities. The company's revenues are derived from rental income, interest and other income, and resident fees and services.